The clinical meaning of levodopa equivalent daily dose in Parkinson's disease-Reference-Cited by-同舟云学术

The clinical meaning of levodopa equivalent daily dose in Parkinson's disease

Published:2021-02-23 Issue:3 Volume:35 Page:620-630
ISSN:0767-3981
Container-title:Fundamental & Clinical Pharmacology
language:en
Short-container-title:Fundam Clin Pharmacol

Author:

Julien Charlotte¹,Hache Guillaume¹^ORCID,Dulac Morgane¹,Dubrou Cléa¹,Castelnovo Giovanni²,Giordana Caroline³,Azulay Jean‐Philippe⁴,Fluchère Frédérique⁴

Affiliation:

1. Assistance Publique Hôpitaux de Marseille Hôpital de la Timone Service de Pharmacie Marseille France

2. Centre Hospitalier Universitaire de Nimes Service de Neurologie Nîmes France

3. Centre Hospitalier Universitaire de Nice Hôpital Pasteur 2 Service de Neurologie Nice France

4. Assistance Publique Hôpitaux de Marseille Hôpital de la Timone Service de Neurologie pathologies du mouvement Centre expert et de coordination interrégional pour la maladie de Parkinson Marseille France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/fcp.12646

Reference78 articles.

1. Parkinson's disease: clinical features and diagnosis

2. Systematic review of levodopa dose equivalency reporting in Parkinson's disease

3. A Real-Life Search for the Optimal Set of Conversion Factors to Levodopa-Equivalent-Dose in Parkinson’s Disease Patients on Polytherapy

4. Continuous subcutaneous apomorphine therapy improves dyskinesias in Parkinson's disease: A prospective study using single‐dose challenges

5. How to dose carbidopa and levodopa extended‐ release capsules (Rytary);Hauser RA;Clin Med J,2015

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the Dominant Factors in Subthalamic Stimulation for Improving Depression in Parkinson's Disease;Movement Disorders Clinical Practice;2024-09-11

2. Dopamine Pathway and Parkinson's Risk Variants Are Associated with Levodopa‐Induced Dyskinesia;Movement Disorders;2024-08-12

3. Two-minute standing endurance test for axial postural abnormalities in patients with Parkinson’s disease;Gait & Posture;2024-07

4. Rehabilitation activities with tablet (REACT) in Parkinson’s disease;Neurological Sciences;2024-02-23

5. Integration of National Health Insurance claims data and animal models reveals fexofenadine as a promising repurposed drug for Parkinson’s disease;Journal of Neuroinflammation;2024-02-21